Additionally, epigenetic changes associated with the PIK3R1 gene remain a focal point of research, and PIK3R1 methylation could potentially serve as a cancer biomarker indicative of malignancy prognosis, as well as a target for multiple miRNAs that perform tumor-suppressive functions, thus providing a robust foundation for future development of specific epigenetic drugs. Here, PIK3R1 is linked to cancer.